Chemours Historical Income Statement
| CC Stock | USD 27.08 0.35 1.31% |
Historical analysis of Chemours income statement accounts such as Interest Expense of 146.3 M or Selling General Administrative of 797.3 M can show how well Chemours Co performed in making a profits. Evaluating Chemours income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Chemours's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Chemours latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Chemours is a good buy for the upcoming year.
Chemours |
About Chemours Income Statement Analysis
Chemours Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Chemours shareholders. The income statement also shows Chemours investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Chemours Income Statement Chart
Chemours Co Income Statement is one of the three primary financial statements used for reporting Chemours's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Chemours revenue and expense. Chemours Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Chemours' Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Reconciled Depreciation is expected to grow to about 330.5 M, whereas Interest Expense is forecasted to decline to about 146.3 M. Add Fundamental
Total Revenue
Total revenue comprises all receipts Chemours generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Chemours Co minus its cost of goods sold. It is profit before Chemours operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Chemours. It is also known as Chemours overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Chemours' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. At present, Chemours' Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Reconciled Depreciation is expected to grow to about 330.5 M, whereas Interest Expense is forecasted to decline to about 146.3 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.4B | 1.6B | 1.3B | 1.2B | Total Revenue | 6.3B | 6.8B | 6.0B | 5.1B |
Chemours income statement Correlations
Click cells to compare fundamentals
Chemours Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Chemours income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 311M | 320M | 317M | 291M | 307M | 313.9M | |
| Interest Expense | 195M | 208M | 210M | 185M | 163M | 146.3M | |
| Selling General Administrative | 548M | 527M | 592M | 710M | 1.3B | 797.3M | |
| Total Revenue | 5.5B | 5.0B | 6.3B | 6.8B | 6.0B | 5.1B | |
| Gross Profit | 1.1B | 1.1B | 1.4B | 1.6B | 1.3B | 1.2B | |
| Other Operating Expenses | 5.1B | 4.5B | 5.7B | 6.0B | 6.1B | 4.5B | |
| Operating Income | 171M | 509M | 888M | 913M | (87M) | (82.7M) | |
| Ebit | 171M | 509M | 888M | 913M | (87M) | (82.7M) | |
| Ebitda | 482M | 829M | 1.2B | 1.2B | 220M | 209M | |
| Cost Of Revenue | 4.5B | 3.9B | 5.0B | 5.2B | 4.7B | 3.8B | |
| Total Operating Expenses | 739M | 628M | 620M | 699M | 1.4B | 918.5M | |
| Income Before Tax | (124M) | 179M | 676M | 741M | (318M) | (302.1M) | |
| Total Other Income Expense Net | (295M) | (330M) | (212M) | (172M) | (231M) | (219.5M) | |
| Net Income | (52M) | 219M | 608M | 578M | (238M) | (226.1M) | |
| Income Tax Expense | (72M) | (40M) | 68M | 163M | (81M) | (77.0M) | |
| Net Income Applicable To Common Shares | (52M) | 219M | 608M | 578M | 520.2M | 355.7M | |
| Net Income From Continuing Ops | (52M) | 219M | 608M | 578M | (237M) | (225.2M) | |
| Tax Provision | (72M) | (40M) | 68M | 163M | (81M) | (77.0M) | |
| Interest Income | 181M | 213M | 142M | 108M | 97.2M | 131.1M | |
| Non Operating Income Net Other | (264M) | 22M | 185M | 132M | 118.8M | 70.6M | |
| Net Interest Income | (195M) | (208M) | (210M) | (185M) | (163M) | (218.4M) | |
| Reconciled Depreciation | 311M | 320M | 317M | 291M | 307M | 330.5M |
Pair Trading with Chemours
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.Moving against Chemours Stock
| 0.59 | DNMR | Danimer Scientific Financial Report 8th of May 2024 | PairCorr |
| 0.58 | ECL | Ecolab Inc Earnings Call This Week | PairCorr |
| 0.55 | CMT | Core Molding Technologies Financial Report 14th of May 2024 | PairCorr |
| 0.53 | ASH | Ashland Global Holdings Earnings Call This Week | PairCorr |
| 0.5 | CBT | Cabot Financial Report 13th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.91) | Dividend Share 1 | Earnings Share (1.60) | Revenue Per Share 40.473 | Quarterly Revenue Growth 0.017 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.